The FORECAST study - Focal recurrent assessment and salvage treatment for radiorecurrent prostate cancer.
Kanthabalan A, Shah T, Arya M, Punwani S, Bomanji J, Haroon A, Illing RO, Latifoltojar A, Freeman A, Jameson C, van der Meulen J, Charman S, Emberton M, Ahmed HU.
Kanthabalan A, et al. Among authors: emberton m.
Contemp Clin Trials. 2015 Sep;44:175-186. doi: 10.1016/j.cct.2015.07.004. Epub 2015 Jul 13.
Contemp Clin Trials. 2015.
PMID: 26184343